170 related articles for article (PubMed ID: 18773878)
1. DNA damage and homologous recombination signaling induced by thymidylate deprivation.
Yang Z; Waldman AS; Wyatt MD
Biochem Pharmacol; 2008 Oct; 76(8):987-96. PubMed ID: 18773878
[TBL] [Abstract][Full Text] [Related]
2. Induction of intrachromosomal homologous recombination in human cells by raltitrexed, an inhibitor of thymidylate synthase.
Waldman BC; Wang Y; Kilaru K; Yang Z; Bhasin A; Wyatt MD; Waldman AS
DNA Repair (Amst); 2008 Oct; 7(10):1624-35. PubMed ID: 18603020
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed's effect on the development of neural tube defects in mice is associated with DNA damage, apoptosis, and proliferation.
Dong Y; Wang X; Zhang J; Guan Z; Xu L; Wang J; Zhang T; Niu B
Mol Cell Biochem; 2015 Jan; 398(1-2):223-31. PubMed ID: 25245820
[TBL] [Abstract][Full Text] [Related]
4. Determination of apoptosis, uracil incorporation, DNA strand breaks, and sister chromatid exchanges under conditions of thymidylate deprivation in a model of BER deficiency.
Li L; Connor EE; Berger SH; Wyatt MD
Biochem Pharmacol; 2005 Nov; 70(10):1458-68. PubMed ID: 16191427
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics.
Yang Z; Waldman AS; Wyatt MD
Biochem Pharmacol; 2012 Mar; 83(6):741-6. PubMed ID: 22222428
[TBL] [Abstract][Full Text] [Related]
6. Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.
Luo Y; Walla M; Wyatt MD
DNA Repair (Amst); 2008 Feb; 7(2):162-9. PubMed ID: 17942376
[TBL] [Abstract][Full Text] [Related]
7. Involvement of base excision repair in response to therapy targeted at thymidylate synthase.
Li L; Berger SH; Wyatt MD
Mol Cancer Ther; 2004 Jun; 3(6):747-53. PubMed ID: 15210861
[TBL] [Abstract][Full Text] [Related]
8. The role of RPA2 phosphorylation in homologous recombination in response to replication arrest.
Shi W; Feng Z; Zhang J; Gonzalez-Suarez I; Vanderwaal RP; Wu X; Powell SN; Roti Roti JL; Gonzalo S; Zhang J
Carcinogenesis; 2010 Jun; 31(6):994-1002. PubMed ID: 20130019
[TBL] [Abstract][Full Text] [Related]
9. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
10. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
11. Uracil in DNA: consequences for carcinogenesis and chemotherapy.
Berger SH; Pittman DL; Wyatt MD
Biochem Pharmacol; 2008 Sep; 76(6):697-706. PubMed ID: 18599024
[TBL] [Abstract][Full Text] [Related]
12. Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells.
Yamashita K; Kiyonari S; Tsubota S; Kishida S; Sakai R; Kadomatsu K
Cancer Sci; 2020 Jul; 111(7):2431-2439. PubMed ID: 32415892
[TBL] [Abstract][Full Text] [Related]
13. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
[TBL] [Abstract][Full Text] [Related]
14. A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination.
Lee DH; Pan Y; Kanner S; Sung P; Borowiec JA; Chowdhury D
Nat Struct Mol Biol; 2010 Mar; 17(3):365-72. PubMed ID: 20154705
[TBL] [Abstract][Full Text] [Related]
15. The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition.
Webley SD; Welsh SJ; Jackman AL; Aherne GW
Br J Cancer; 2001 Aug; 85(3):446-52. PubMed ID: 11487279
[TBL] [Abstract][Full Text] [Related]
16. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
18. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of cell death following thymidylate synthase inhibition: 2'-deoxyuridine-5'-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole.
Curtin NJ; Harris AL; Aherne GW
Cancer Res; 1991 May; 51(9):2346-52. PubMed ID: 2015598
[TBL] [Abstract][Full Text] [Related]
20. Thymidine and hypoxanthine protection patterns of the folic acid-enhanced synergies for combinations of trimetrexate plus a polyglutamylatable inhibitor of purine or thymidylate synthesis against human ileocecal HCT-8 cells.
Faessel HM; Slocum HK; Rustum YM; Greco WR
Int J Oncol; 2003 Aug; 23(2):401-9. PubMed ID: 12851689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
